• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: AV-TEMECULA-CT ABSORB BIORESORBABLE VASCULAR SCAFFOLD SYSTEM; DRUG ELUTING CORONARY STENT SYSTEM

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

AV-TEMECULA-CT ABSORB BIORESORBABLE VASCULAR SCAFFOLD SYSTEM; DRUG ELUTING CORONARY STENT SYSTEM Back to Search Results
Catalog Number 1012464-12
Device Problems Peeled/Delaminated (1454); Failure to Advance (2524)
Patient Problem No Consequences Or Impact To Patient (2199)
Event Date 05/12/2014
Event Type  malfunction  
Event Description
The procedure was to treat a heavily calcified lesion in a coronary artery.Using a radial access site, the lesion was pre-dilated with a nc 3.5x8 mm balloon catheter.The residual stenosis was below 40%.The 3.5x12 mm device could not cross because of the heavy calcification.A xience pro x was placed with success.There was no clinically significant delay in the procedure and no adverse patient effects.No additional information was provided.The returned device revealed that there was balloon peeling.
 
Manufacturer Narrative
(b)(4).Evaluation summary: the device was returned for analysis.The reported failure to advance could not be replicated in a testing environment as it was based on operational circumstances.However, balloon peeling was noted.Based on the visual and dimensional analysis of the device, there is no indication of a product deficiency.A review of the lot history record revealed no non-conformances that would have contributed to the reported event.A query of the complaint handling database revealed no other incidents for failure to advance reported from this lot.Based on the information reviewed, there is no indication of a product deficiency.Though the device is not approved for sale in the u.S., it uses a delivery system which is similar to a device sold in the u.S.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ABSORB BIORESORBABLE VASCULAR SCAFFOLD SYSTEM
Type of Device
DRUG ELUTING CORONARY STENT SYSTEM
Manufacturer (Section D)
AV-TEMECULA-CT
abbott vascular
26531 ynez road
temecula CA 92591 462
Manufacturer (Section G)
ABBOTT VASCULAR, TEMECULA, CA USA REG# 2024168
abbott vascular
26531 ynez road
temecula CA 92591 462
Manufacturer Contact
connie speck
abbott vascular
26531 ynez road
temecula, CA 92591-4628
9519143996
MDR Report Key3930309
MDR Text Key14877047
Report Number2024168-2014-04471
Device Sequence Number1
Product Code NIQ
Combination Product (y/n)N
Reporter Country CodeGM
PMA/PMN Number
P070015
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Health Professional,Company Representative
Reporter Occupation Health Professional
Remedial Action Other
Type of Report Initial
Report Date 05/21/2014
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received07/11/2014
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date08/06/2014
Device Catalogue Number1012464-12
Device Lot Number308076A
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer06/11/2014
Is the Reporter a Health Professional? Yes
Date Manufacturer Received06/19/2014
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured08/01/2013
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Treatment
GUIDE CATH: 6FR
-
-